US
ProShares Ultra Nasdaq Biotechnology
BIB · Equity
$85.10
+2.29%
Assets
n/a
Expense ratio
0.95%
Holdings
263
1Y return
+114.9%
Forward P/E
n/a
Top 10 holdings
+152.4%
Return and risk
| 1Y total return | +114.9% |
| 3Y total return | +54.4% |
| 5Y total return | +8.1% |
| 3Y CAGR | +15.6% |
| 5Y CAGR | +1.6% |
| Beta | 1.25 |
| RSI | 52.95 |
Fund structure
| Asset class | Equity |
| Assets | n/a |
| Holdings | 263 |
| Expense ratio | 0.95% |
| Dividend yield | +0.6% |
| Top 10 holdings | +152.4% |
| Volume | 5K |
All ETF indicators
| All Time High | 113.06 |
| All Time High Change | -25.31 |
| All Time High Date | 2021-02-10 |
| All Time Low | 4.24 |
| All Time Low Change | 1,891.28 |
| All Time Low Date | 2011-08-08 |
| Atr | 2.96 |
| Beta | 1.25 |
| Cagr10y | 8.33 |
| Cagr15y | 15.55 |
| Cagr1y | 115.03 |
| Cagr3y | 15.58 |
| Cagr5y | 1.56 |
| Ch10y | 116.54 |
| Ch15y | 750.97 |
| Ch1m | 3.54 |
| Ch1w | 2.32 |
| Ch1y | 113.1 |
| Ch3m | -0.5 |
| Ch3y | 50.32 |
| Ch5y | 5.16 |
| Ch6m | 12 |
| Ch YTD | 5.86 |
| Close | 83.19 |
| Div CAGR3 | 191.74 |
| Div CAGR5 | 90.11 |
| Dividend Growth | -47.84 |
| Dividend Growth Years | 0 |
| Dividend Years | 5 |
| Dividend Yield | 0.58 |
| Dps | 0.49 |
| Ex Div Date | 2026-03-25 |
| High52 | 90.91 |
| High52ch | -6.39 |
| High52 Date | 2026-02-25 |
| Inception Date | 2010-04-08 |
| Isin | US74347R2141 |
| Last Dividend | 0.01 |
| Low52 | 39.56 |
| Low52ch | 115.1 |
| Low52 Date | 2025-05-14 |
| Ma150 | 79.76 |
| Ma150ch | 5.89 |
| Ma20 | 84.07 |
| Ma200 | 73.83 |
| Ma200ch | 14.39 |
| Ma20ch | 0.46 |
| Ma50 | 82 |
| Ma50ch | 2.99 |
| Payment Date | 2026-03-31 |
| Payout Frequency | Quarterly |
| Price Date | 2026-05-12 |
| Rsi | 52.95 |
| Rsi Monthly | 64.66 |
| Rsi Weekly | 56.46 |
| Sharpe Ratio | 2 |
| Sortino Ratio | 3.43 |
| Top10holdings | 152.36 |
| Tr10y | 122.51 |
| Tr15y | 774.45 |
| Tr1m | 3.54 |
| Tr1y | 114.92 |
| Tr3m | -0.49 |
| Tr3y | 54.41 |
| Tr5y | 8.05 |
| Tr6m | 12.19 |
| Tr YTD | 5.86 |